FDA Says It Caved To Politics In Clearing ReGen Implant
The U.S. Food and Drug Administration said Thursday it had acted within its authority when it rescinded marketing clearance for a ReGen Biologics Inc. knee implant — an action the company...To view the full article, register now.
Already a subscriber? Click here to view full article